Literature DB >> 3044720

[Endosonographic findings of benign and malignant lesions in the stomach wall. A prospective comparison with conventional imaging study procedures].

A Polensky1, K Ziegler, C Sanft, M Gregor, M Friedrich, H Stein, E O Riecken.   

Abstract

The results of endoscopic ultrasonography in the diagnosis and differentiation of benign and malignant lesions of the stomach was prospectively compared with those obtained by upper endoscopy with biopsy, double-contrast radiography and computed tomography in 15 patients with benign and 26 with malignant gastric lesions. The validity of the methods was established by comparing the results obtained with the long-term course observed clinically in conjunction with an endoscopic-histological follow-up or with the findings on histopathological examination of the operative specimen. Precise diagnosis of the lesion was made by endoscopic ultrasonography in about 90% of cases, a result better than that obtained with radiography or computed tomography. Furthermore, endoscopic ultrasonography had good sensitivity for demonstrating perigastric lymph node enlargement; in this respect it was better than computed tomography, but was not able to distinguish whether the enlargement was benign or malignant: this will only become possible with technical improvement of the instruments.

Entities:  

Mesh:

Year:  1988        PMID: 3044720     DOI: 10.1055/s-2008-1067803

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

Review 1.  Preoperative staging of gastrointestinal tumors by endosonography.

Authors:  K Ziegler; C Sanft; M Zeitz; E O Riecken
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

Review 2.  Medical imaging.

Authors:  L Kreel
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

3.  Evaluation of endosonography in TN staging of oesophageal cancer.

Authors:  K Ziegler; C Sanft; M Zeitz; M Friedrich; H Stein; R Häring; E O Riecken
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.